Abstract
A monoclonal antibody raised against the high molecular weight melanoma antigen was labelled with indium-111 and injected intravenously into 25 patients with malignant melanoma. The results obtained from images at 24 and 96 h post i.v. administration of the antibody were compared with results obtained from computerised tomography studies with regard to detection of previously unrecognised sites of metastatic disease and apparent false positive localisation. Detailed study of the patients' clinical condition and detection rates using the two methods suggest that both methods detect approximately 80% of clinically and pathologically confirmed metastases. Of 62 known metastases, the antibody detected 50 (81%), with 17 false positive results. False negatives were most common in the lung. In eight patients the two methods were considered of equal value, in 10 the monoclonal gave a greater amount of clinically relevant information, and in seven the CT was superior. In three patients clinically significant metastatic lesions were detected by the radiolabelled monoclonal and had not been previously recognised either by CT scanning or on clinical grounds. No patients had any adverse reaction to the antibody and in the course of our study the dose of antibody was reduced from 20 mg to 200 micrograms with no apparent loss of sensitivity. In at least two patients uptake of the labelled monoclonal into tumour sites would have been adequate for effective targeted radiotherapy.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Buraggi G. L., Callegaro L., Mariani G., Turrin A., Cascinelli N., Attili A., Bombardieri E., Terno G., Plassio G., Dovis M. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments. Cancer Res. 1985 Jul;45(7):3378–3387. [PubMed] [Google Scholar]
- Cerny T., Owens S. E., Mackenzie S. A., Nuttall P. M., Gosh A. K., Smith D. B., Thatcher N. Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma. Eur J Nucl Med. 1987;13(3):130–133. doi: 10.1007/BF00289024. [DOI] [PubMed] [Google Scholar]
- Kirkwood J. M., Neumann R. D., Zoghbi S. S., Ernstoff M. S., Cornelius E. A., Shaw C., Ziyadeh T., Fine J. A., Unger M. W. Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018). J Clin Oncol. 1987 Aug;5(8):1247–1255. doi: 10.1200/JCO.1987.5.8.1247. [DOI] [PubMed] [Google Scholar]
- Larson S. M. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture. Radiology. 1987 Nov;165(2):297–304. doi: 10.1148/radiology.165.2.3498971. [DOI] [PubMed] [Google Scholar]
- Lotze M. T., Carrasquillo J. A., Weinstein J. N., Bryant G. J., Perentesis P., Reynolds J. C., Matis L. A., Eger R. R., Keenan A. M., Hellström I. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection. Ann Surg. 1986 Sep;204(3):223–235. doi: 10.1097/00000658-198609000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Siccardi A. G., Buraggi G. L., Callegaro L., Mariani G., Natali P. G., Abbati A., Bestagno M., Caputo V., Mansi L., Masi R. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res. 1986 Sep;46(9):4817–4822. [PubMed] [Google Scholar]
- Taylor A., Jr, Milton W., Eyre H. P., Christian P., Wu F., Hagan P., Alazraki N., Datz F. L., Unger M. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody. J Nucl Med. 1988 Mar;29(3):329–337. [PubMed] [Google Scholar]